malaysiameds

Fifteen years after Viagra’s launch, the little blue pill still holds 45% of the global market for treatments to address erectile dysfunction. But a new drug may have the potential to challenge Pfizer’s dominance and provide men with even more options. Researchers at Futura Medical found that a heart medication they developed – GTN – … Read more